These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 15639189)
41. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia. Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250 [TBL] [Abstract][Full Text] [Related]
42. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. Lee HH; Chao HT; Ng HT; Choo KB J Med Genet; 1996 May; 33(5):371-5. PubMed ID: 8733045 [TBL] [Abstract][Full Text] [Related]
43. Single-nucleotide polymorphisms in intron 2 of CYP21P: evidence for a higher rate of mutation at CpG dinucleotides in the functional steroid 21-hydroxylase gene and application to segregation analysis in congenital adrenal hyperplasia. Jiddou RR; Wei WL; Sane KS; Killeen AA Clin Chem; 1999 May; 45(5):625-9. PubMed ID: 10222348 [TBL] [Abstract][Full Text] [Related]
44. Two distinct areas of unequal crossingover within the steroid 21-hydroxylase genes produce absence of CYP21B. Donohoue PA; Jospe N; Migeon CJ; Van Dop C Genomics; 1989 Oct; 5(3):397-406. PubMed ID: 2613228 [TBL] [Abstract][Full Text] [Related]
45. Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome. Miller WL; Merke DP Horm Res Paediatr; 2018; 89(5):352-361. PubMed ID: 29734195 [TBL] [Abstract][Full Text] [Related]
46. Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency. Paragliola RM; Perrucci A; Foca L; Urbani A; Concolino P J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807105 [TBL] [Abstract][Full Text] [Related]
47. Congenital adrenal hyperplasia with a Ivo CR; Fitas AL; Madureira I; Diamantino C; Gomes S; Gonçalves J; Lopes L J Pediatr Endocrinol Metab; 2023 Jan; 36(1):81-85. PubMed ID: 36259452 [TBL] [Abstract][Full Text] [Related]
48. Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions. Mao R; Nelson L; Kates R; Miller CE; Donaldson DL; Tang W; Ward K Prenat Diagn; 2002 Dec; 22(13):1171-6. PubMed ID: 12478627 [TBL] [Abstract][Full Text] [Related]
49. A novel frameshift mutation (141delT) in exon 1 of the 21-hydroxylase gene (CYP21) in a patient with the salt wasting form of congenital adrenal hyperplasia. Mutation in brief no. 255. Online. Krone N; Braun A; Roscher AA; Schwarz HP Hum Mutat; 1999; 14(1):90-1. PubMed ID: 10447270 [TBL] [Abstract][Full Text] [Related]
50. Organization of C4 and CYP21 loci in gorilla and orangutan. Kawaguchi H; Klein J Hum Immunol; 1992 Mar; 33(3):153-62. PubMed ID: 1618655 [TBL] [Abstract][Full Text] [Related]
51. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction. Owerbach D; Ballard AL; Draznin MB J Clin Endocrinol Metab; 1992 Mar; 74(3):553-8. PubMed ID: 1740489 [TBL] [Abstract][Full Text] [Related]
52. Congenital adrenal hyperplasia, ovarian failure and Ehlers-Danlos syndrome due to a 6p deletion. Moysés-Oliveira M; Mancini TI; Takeno SS; Rodrigues AD; Bachega TA; Bertola D; Melaragno MI Sex Dev; 2014; 8(4):139-45. PubMed ID: 24970489 [TBL] [Abstract][Full Text] [Related]
53. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. L'Allemand D; Tardy V; Grüters A; Schnabel D; Krude H; Morel Y J Clin Endocrinol Metab; 2000 Dec; 85(12):4562-7. PubMed ID: 11134109 [TBL] [Abstract][Full Text] [Related]
54. Evaluating the efficacy of a long-read sequencing-based approach in the clinical diagnosis of neonatal congenital adrenocortical hyperplasia. Zhang R; Cui D; Song C; Ma X; Cai N; Zhang Y; Feng M; Cao Y; Chen L; Qiang R Clin Chim Acta; 2024 Mar; 555():117820. PubMed ID: 38307397 [TBL] [Abstract][Full Text] [Related]
55. Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia. Vrzalová Z; Hrubá Z; Hrabincová ES; Vrábelová S; Votava F; Koloušková S; Fajkusová L Eur J Med Genet; 2011; 54(2):112-7. PubMed ID: 20970527 [TBL] [Abstract][Full Text] [Related]
56. Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia. Nunez BS; Lobato MN; White PC; Meseguer A Biochem Biophys Res Commun; 1999 Sep; 262(3):635-7. PubMed ID: 10471376 [TBL] [Abstract][Full Text] [Related]
57. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Tusié-Luna MT; White PC Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10796-800. PubMed ID: 7479886 [TBL] [Abstract][Full Text] [Related]
58. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH). Concolino P Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686 [TBL] [Abstract][Full Text] [Related]
59. [From gene to disease: adrenogenital syndrome and the CYP21A2 gene]. Claahsen-van der Grinten HL; Hoefsloot LH Ned Tijdschr Geneeskd; 2007 May; 151(21):1174-7. PubMed ID: 17557757 [TBL] [Abstract][Full Text] [Related]
60. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects. Chen W; Kim MS; Shanbhag S; Arai A; VanRyzin C; McDonnell NB; Merke DP Am J Med Genet A; 2009 Dec; 149A(12):2803-8. PubMed ID: 19921645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]